{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:10:08Z","timestamp":1789258208256,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,12]]},"DOI":"10.7759\/cureus.116152","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:36:58Z","timestamp":1789256218000},"source":"Crossref","is-referenced-by-count":0,"title":["Alternative Medicine and Nutritional Therapy in Adult Inflammatory Bowel Disease in India: A Move Towards Holistic Practice"],"prefix":"10.7759","author":[{"given":"Prerana","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Varshney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan Q","year":"2019","unstructured":"Guan Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019, 2019:7247238. 10.1155\/2019\/7247238","journal-title":"J Immunol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15801","article-title":"Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium","volume":"37","author":"Banerjee R","year":"2022","unstructured":"Banerjee R, Pal P, Hilmi I, et al.. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium. J Gastroenterol Hepatol. 2022, 37:1004-15. 10.1111\/jgh.15801","journal-title":"J Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0233-2","article-title":"Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific","volume":"114","author":"Ng SC","year":"2019","unstructured":"Ng SC, Kaplan GG, Tang W, et al.. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019, 114:107-15. 10.1038\/s41395-018-0233-2","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000465522","article-title":"Epidemiology of inflammatory bowel disease in India: the great shift east","volume":"2","author":"Kedia S","year":"2017","unstructured":"Kedia S, Ahuja V. Epidemiology of inflammatory bowel disease in India: the great shift east. Inflamm Intest Dis. 2017, 2:102-15. 10.1159\/000465522","journal-title":"Inflamm Intest Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan GG","year":"2015","unstructured":"Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015, 12:720-7. 10.1038\/nrgastro.2015.150","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16445","article-title":"Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents","volume":"54","author":"van Linschoten RC","year":"2021","unstructured":"van Linschoten RC, Visser E, Niehot CD, van der Woude CJ, Hazelzet JA, van Noord D, West RL. Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Aliment Pharmacol Ther. 2021, 54:234-48. 10.1111\/apt.16445","journal-title":"Aliment Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4690-z","article-title":"Cost of illness in inflammatory bowel disease","volume":"62","author":"Kamat N","year":"2017","unstructured":"Kamat N, Ganesh Pai C, Surulivel Rajan M, Kamath A. Cost of illness in inflammatory bowel disease. Dig Dis Sci. 2017, 62:2318-26. 10.1007\/s10620-017-4690-z","journal-title":"Dig Dis Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2020.04.007","article-title":"Importance of evidence-based health insurance reimbursement and health technology assessment for achieving universal health coverage and improved access to health in India","volume":"24","author":"Dang A","year":"2021","unstructured":"Dang A, Dang D, Vallish BN. Importance of evidence-based health insurance reimbursement and health technology assessment for achieving universal health coverage and improved access to health in India. Value Health Reg Issues. 2021, 24:24-30. 10.1016\/j.vhri.2020.04.007","journal-title":"Value Health Reg Issues"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001480","article-title":"Impact of demographic, clinical and psychosocial variables on drug adherence and outcomes in Indian patients with inflammatory bowel disease: cost is not the only factor!","volume":"55","author":"Banerjee R","year":"2021","unstructured":"Banerjee R, Pal P, Adigopula B, Reddy DN. Impact of demographic, clinical and psychosocial variables on drug adherence and outcomes in Indian patients with inflammatory bowel disease: cost is not the only factor!. J Clin Gastroenterol. 2021, 55:e92-9. 10.1097\/MCG.0000000000001480","journal-title":"J Clin Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00062-6","article-title":"Managing inflammatory bowel disease: what to do when the best is unaffordable?","volume":"8","author":"Banerjee R","year":"2023","unstructured":"Banerjee R, Raghunathan N, Pal P. Managing inflammatory bowel disease: what to do when the best is unaffordable?. Lancet Gastroenterol Hepatol. 2023, 8:396-8. 10.1016\/S2468-1253(23)00062-6","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30298-3","article-title":"Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia","volume":"5","author":"Ng SC","year":"2020","unstructured":"Ng SC, Mak JWY, Pal P, Banerjee R. Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia. Lancet Gastroenterol Hepatol. 2020, 5:1089-100. 10.1016\/S2468-1253(20)30298-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2020.00010","article-title":"Trends of inflammatory bowel disease at a tertiary care center in northern India","volume":"19","author":"Sood A","year":"2021","unstructured":"Sood A, Kaur K, Singh A, et al.. Trends of inflammatory bowel disease at a tertiary care center in northern India. Intest Res. 2021, 19:282-90. 10.5217\/ir.2020.00010","journal-title":"Intest Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09169","article-title":"Colitis and Crohn's Foundation (India): a first nationwide inflammatory bowel disease registry","volume":"19","author":"Sood A","year":"2021","unstructured":"Sood A, Kaur K, Mahajan R, et al.. Colitis and Crohn's Foundation (India): a first nationwide inflammatory bowel disease registry. Intest Res. 2021, 19:206-16. 10.5217\/ir.2019.09169","journal-title":"Intest Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2016.14.3.218","article-title":"Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries","volume":"14","author":"Wei SC","year":"2016","unstructured":"Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res. 2016, 14:218-23. 10.5217\/ir.2016.14.3.218","journal-title":"Intest Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02978-y","article-title":"Factors contributing to flares of ulcerative colitis in North India - a case-control study","volume":"23","author":"Rana VS","year":"2023","unstructured":"Rana VS, Mahajan G, Patil AN, et al.. Factors contributing to flares of ulcerative colitis in North India - a case-control study. BMC Gastroenterol. 2023, 23:336. 10.1186\/s12876-023-02978-y","journal-title":"BMC Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300613","article-title":"Role of biological therapy for inflammatory bowel disease in developing countries","volume":"61","author":"Rogler G","year":"2012","unstructured":"Rogler G, Bernstein CN, Sood A, Goh KL, Yamamoto-Furusho JK, Abbas Z, Fried M. Role of biological therapy for inflammatory bowel disease in developing countries. Gut. 2012, 61:706-12. 10.1136\/gutjnl-2011-300613","journal-title":"Gut"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19209","article-title":"Biologics for the management of inflammatory bowel disease: a review in tuberculosis-endemic countries","volume":"14","author":"Banerjee R","year":"2020","unstructured":"Banerjee R, Ali RA, Wei SC, Adsul S. Biologics for the management of inflammatory bowel disease: a review in tuberculosis-endemic countries. Gut Liver. 2020, 14:685-98. 10.5009\/gnl19209","journal-title":"Gut Liver"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e107","article-title":"The risk of tuberculosis in patients with inflammatory bowel disease treated with vedolizumab or ustekinumab in Korea","volume":"37","author":"Choi MG","year":"2022","unstructured":"Choi MG, Ye BD, Yang SK, Shim TS, Jo KW, Park SH. The risk of tuberculosis in patients with inflammatory bowel disease treated with vedolizumab or ustekinumab in Korea. J Korean Med Sci. 2022, 37:e107. 10.3346\/jkms.2022.37.e107","journal-title":"J Korean Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00336-8","article-title":"Addressing unmet needs from a new frontier of IBD: the South Asian IBD Alliance","volume":"6","author":"Aswani-Omprakash T","year":"2021","unstructured":"Aswani-Omprakash T, Sharma V, Bishu S, et al.. Addressing unmet needs from a new frontier of IBD: the South Asian IBD Alliance. Lancet Gastroenterol Hepatol. 2021, 6:884-5. 10.1016\/S2468-1253(21)00336-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.09.007","article-title":"Identifying care challenges as opportunities for research and education in inflammatory bowel disease in South Asia","volume":"20","author":"Balasubramaniam M","year":"2022","unstructured":"Balasubramaniam M, Nandi N, Aswani-Omprakash T, Sebastian S, Sharma V, Deepak P. Identifying care challenges as opportunities for research and education in inflammatory bowel disease in South Asia. Clin Gastroenterol Hepatol. 2022, 20:2421-6. 10.1016\/j.cgh.2022.09.007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/joa.joa_120_21","article-title":"India as global center for traditional medicine: needs, initiatives, and challenges","volume":"17","author":"Mohan R","year":"2023","unstructured":"Mohan R, Pandey V, Kurien N. India as global center for traditional medicine: needs, initiatives, and challenges. J Ayurveda. 2023, 17:150-3. 10.4103\/joa.joa_120_21","journal-title":"J Ayurveda"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.004","article-title":"Complementary and alternative medicines used by patients with inflammatory bowel diseases","volume":"152","author":"Cheifetz AS","year":"2017","unstructured":"Cheifetz AS, Gianotti R, Luber R, Gibson PR. Complementary and alternative medicines used by patients with inflammatory bowel diseases. Gastroenterology. 2017, 152:415-429.e15. 10.1053\/j.gastro.2016.10.004","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/nu16070934","article-title":"Herbal medicines for the treatment of active ulcerative colitis: a systematic review and meta-analysis","volume":"16","author":"Iyengar P","year":"2024","unstructured":"Iyengar P, Godoy-Brewer G, Maniyar I, White J, Maas L, Parian AM, Limketkai B. Herbal medicines for the treatment of active ulcerative colitis: a systematic review and meta-analysis. Nutrients. 2024, 16:934. 10.3390\/nu16070934","journal-title":"Nutrients"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/ijcm.ijcm_282_22","article-title":"Perspective toward complementary & alternative medicines in the prevention of COVID-19 infection","volume":"48","author":"Agrawal A","year":"2023","unstructured":"Agrawal A, Sharma A, Mathur M, Sharma A, Modi G, Patel T. Perspective toward complementary & alternative medicines in the prevention of COVID-19 infection. Indian J Community Med. 2023, 48:401-6. 10.4103\/ijcm.ijcm_282_22","journal-title":"Indian J Community Med"},{"key":"ref25","article-title":"Knowledge, attitude and practice of complementary and alternative medicine (CAM) among medical practitioners","volume":"3","author":"Kong FH","year":"2013","unstructured":"Kong FH, Man LK, Shetty RS, Kamath VG. Knowledge, attitude and practice of complementary and alternative medicine (CAM) among medical practitioners. IJRRMS. 2013, 3:5-9.","journal-title":"IJRRMS"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.25259\/NMJI_63_21","article-title":"Knowledge, attitude and practice towards Ayurveda among patients attending cardiology and neurology clinics at a tertiary care institute in India","volume":"36","author":"Sharma G","year":"2023","unstructured":"Sharma G, Sharma V, Mridula MK, et al.. Knowledge, attitude and practice towards Ayurveda among patients attending cardiology and neurology clinics at a tertiary care institute in India. Natl Med J India. 2023, 36:145-9. 10.25259\/NMJI_63_21","journal-title":"Natl Med J India"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/ijcm.ijcm_657_22","article-title":"Prevalence, pattern, and predictors of ever use of complementary and alternative medicine in diabetes and hypertension: a cross-sectional study","volume":"48","author":"Walia P","year":"2023","unstructured":"Walia P, Kumari R, Singh M. Prevalence, pattern, and predictors of ever use of complementary and alternative medicine in diabetes and hypertension: a cross-sectional study. Indian J Community Med. 2023, 48:627-32. 10.4103\/ijcm.ijcm_657_22","journal-title":"Indian J Community Med"},{"key":"ref28","article-title":"The use of complementary and alternative medicine in patients with inflammatory bowel disease","volume":"14","author":"Lin SC","year":"2018","unstructured":"Lin SC, Cheifetz AS. The use of complementary and alternative medicine in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2018, 14:415-25.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820927550","article-title":"Complementary and alternative medications in the management of inflammatory bowel disease","volume":"13","author":"Picardo S","year":"2020","unstructured":"Picardo S, Altuwaijri M, Devlin SM, Seow CH. Complementary and alternative medications in the management of inflammatory bowel disease. Ther Adv Gastroenterol. 2020, 13:10.1177\/1756284820927550","journal-title":"Ther Adv Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.153418","article-title":"Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India","volume":"47","author":"Roy V","year":"2015","unstructured":"Roy V, Gupta M, Ghosh RK. Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India. Indian J Pharmacol. 2015, 47:137-42. 10.4103\/0253-7613.153418","journal-title":"Indian J Pharmacol"},{"key":"ref31","article-title":"Pattern of medical pluralism in patients under treatment for lifestyle diseases in a tertiary level hospital in Uttarakhand","volume":"116","author":"Kumari R","year":"2018","unstructured":"Kumari R, Gupta P, Nath B. Pattern of medical pluralism in patients under treatment for lifestyle diseases in a tertiary level hospital in Uttarakhand. J Indian Med Assoc. 2018, 116:19-24.","journal-title":"J Indian Med Assoc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001416","article-title":"Novel bioenhanced curcumin with mesalamine for induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis: a randomized double-blind placebo-controlled pilot study","volume":"55","author":"Banerjee R","year":"2021","unstructured":"Banerjee R, Pal P, Penmetsa A, Kathi P, Girish G, Goren I, Reddy DN. Novel bioenhanced curcumin with mesalamine for induction of clinical and endoscopic remission in mild-to-moderate ulcerative colitis: a randomized double-blind placebo-controlled pilot study. J Clin Gastroenterol. 2021, 55:702-8. 10.1097\/MCG.0000000000001416","journal-title":"J Clin Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.08.008","article-title":"Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial","volume":"4","author":"Hanai H","year":"2006","unstructured":"Hanai H, Iida T, Takeuchi K, et al.. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006, 4:1502-6. 10.1016\/j.cgh.2006.08.008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.02.019","article-title":"Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial","volume":"13","author":"Lang A","year":"2015","unstructured":"Lang A, Salomon N, Wu JC, et al.. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 2015, 13:1444-9.e1. 10.1016\/j.cgh.2015.02.019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6581","article-title":"The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis","volume":"34","author":"Sadeghi N","year":"2020","unstructured":"Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res. 2020, 34:1123-33. 10.1002\/ptr.6581","journal-title":"Phytother Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.08.006","article-title":"Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis \u2014 a randomized, placebo-controlled, pilot study","volume":"8","author":"Singla V","year":"2014","unstructured":"Singla V, Pratap Mouli V, Garg SK, et al.. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis \u2014 a randomized, placebo-controlled, pilot study. J Crohns Colitis. 2014, 8:208-14. 10.1016\/j.crohns.2013.08.006","journal-title":"J Crohns Colitis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.05.023","article-title":"Curcumin-QingDai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial","volume":"22","author":"Ben-Horin S","year":"2024","unstructured":"Ben-Horin S, Salomon N, Karampekos G, et al.. Curcumin-QingDai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial. Clin Gastroenterol Hepatol. 2024, 22:347-356.e6. 10.1016\/j.cgh.2023.05.023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.08.041","article-title":"Oral curcumin no more effective than placebo in preventing recurrence of Crohn's disease after surgery in a randomized controlled trial","volume":"18","author":"Bommelaer G","year":"2020","unstructured":"Bommelaer G, Laharie D, Nancey S, et al.. Oral curcumin no more effective than placebo in preventing recurrence of Crohn's disease after surgery in a randomized controlled trial. Clin Gastroenterol Hepatol. 2020, 18:1553-1560.e1. 10.1016\/j.cgh.2019.08.041","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa097","article-title":"Highly bioavailable curcumin derivative ameliorates Crohn's disease symptoms: a randomized, double-blind, multicenter study","volume":"14","author":"Sugimoto K","year":"2020","unstructured":"Sugimoto K, Ikeya K, Bamba S, et al.. Highly bioavailable curcumin derivative ameliorates Crohn's disease symptoms: a randomized, double-blind, multicenter study. J Crohns Colitis. 2020, 14:1693-701. 10.1093\/ecco-jcc\/jjaa097","journal-title":"J Crohns Colitis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.70082\/92te2e85","article-title":"Clinical study of Pathadya Churna in the management of ulcerative colitis","volume":"21","author":"Singh S","year":"2025","unstructured":"Singh S, Kushwah S, Pedhekar SR, Antiwal M, Tripathi JS, Yadav DP. Clinical study of Pathadya Churna in the management of ulcerative colitis. Rev Diab Stud. 2025, 21:989-1003. 10.70082\/92te2e85","journal-title":"Rev Diab Stud"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4103\/0974-8520.82046","article-title":"Effects of Ayurvedic treatment on forty-three patients of ulcerative colitis","volume":"31","author":"Patel MV","year":"2010","unstructured":"Patel MV, Patel KB, Gupta SN. Effects of Ayurvedic treatment on forty-three patients of ulcerative colitis. Ayu. 2010, 31:478-81. 10.4103\/0974-8520.82046","journal-title":"Ayu"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2014.08.005","article-title":"Triphala, an Ayurvedic formulation improves the antioxidant status on TNBS induced IBD in rats","volume":"6","author":"Koppikar SJ","year":"2014","unstructured":"Koppikar SJ, Jagtap SD, Devarshi PP, Jangle NM, Awad VB, Wele AA, Harsulkar AM. Triphala, an Ayurvedic formulation improves the antioxidant status on TNBS induced IBD in rats. Eur J Integr Med. 2014, 6:646-56. 10.1016\/j.eujim.2014.08.005","journal-title":"Eur J Integr Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.18311\/jnr\/2022\/29781","article-title":"Formulation, standardization, and preclinical evaluation of polyherbal suspension against inflammatory bowel disease","volume":"22","author":"Dubey P","year":"2022","unstructured":"Dubey P, Begum RF, Chitra V, Mrinalini R, Gunasekaran H, Sumithra M. Formulation, standardization, and preclinical evaluation of polyherbal suspension against inflammatory bowel disease. J Nat Remedies. 2022, 22:412-23. 10.18311\/jnr\/2022\/29781","journal-title":"J Nat Remedies"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2026.103465","article-title":"Complete clinical and endoscopic remission in severe ulcerative pancolitis following personalized Ayurveda management: a case report","volume":"22","author":"Joshi SS","year":"2026","unstructured":"Joshi SS, Saini D, Ghildiyal S, Deogade MS. Complete clinical and endoscopic remission in severe ulcerative pancolitis following personalized Ayurveda management: a case report. Explore (NY). 2026, 22:103465. 10.1016\/j.explore.2026.103465","journal-title":"Explore (NY)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.4103\/jism.jism_6_23","article-title":"Management of inflammatory bowel disease with Ayurveda: a case report","volume":"11","author":"Subraya MT","year":"2023","unstructured":"Subraya MT. Management of inflammatory bowel disease with Ayurveda: a case report. J Indian Syst Med. 2023, 11:131-9. 10.4103\/jism.jism_6_23","journal-title":"J Indian Syst Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2025.101227","article-title":"Remission in ulcerative colitis with standalone Ayurveda intervention: a case report","volume":"16","author":"Rastogi S","year":"2025","unstructured":"Rastogi S, Sharma KG. Remission in ulcerative colitis with standalone Ayurveda intervention: a case report. J Ayurveda Integr Med. 2025, 16:101227. 10.1016\/j.jaim.2025.101227","journal-title":"J Ayurveda Integr Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-13-349","article-title":"Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicine","volume":"13","author":"Lindberg A","year":"2013","unstructured":"Lindberg A, Ebbeskog B, Karlen P, Oxelmark L. Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicine. BMC Complement Altern Med. 2013, 13:349. 10.1186\/1472-6882-13-349","journal-title":"BMC Complement Altern Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2012.00794.x","article-title":"Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies","volume":"17","author":"Chung VC","year":"2014","unstructured":"Chung VC, Ma PH, Lau CH, Wong SY, Yeoh EK, Griffiths SM. Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies. Health Expect. 2014, 17:622-36. 10.1111\/j.1369-7625.2012.00794.x","journal-title":"Health Expect"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2014.11.002","article-title":"Mainstreaming of Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy with the health care delivery system in India","volume":"5","author":"Shrivastava SR","year":"2015","unstructured":"Shrivastava SR, Shrivastava PS, Ramasamy J. Mainstreaming of Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy with the health care delivery system in India. J Tradit Complement Med. 2015, 5:116-8. 10.1016\/j.jtcme.2014.11.002","journal-title":"J Tradit Complement Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101500","article-title":"Inflammatory bowel disease in India: challenges and opportunities","volume":"12","author":"Snell A","year":"2021","unstructured":"Snell A, Segal J, Limdi J, Banerjee R. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol. 2021, 12:390-6. 10.1136\/flgastro-2020-101500","journal-title":"Frontline Gastroenterol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11146","article-title":"Dietary therapies for adult and pediatric inflammatory bowel disease","volume":"39","author":"Deas J","year":"2024","unstructured":"Deas J, Shah ND, Konijeti GG, Lundin A, Lanser O, Magavi P, Ali S. Dietary therapies for adult and pediatric inflammatory bowel disease. Nutr Clin Pract. 2024, 39:530-45. 10.1002\/ncp.11146","journal-title":"Nutr Clin Pract"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The medical management of paediatric Crohn's disease: an ECCO-ESPGHAN guideline update","volume":"15","author":"van Rheenen PF","year":"2021","unstructured":"van Rheenen PF, Aloi M, Assa A, et al.. The medical management of paediatric Crohn's disease: an ECCO-ESPGHAN guideline update. J Crohns Colitis. 2021, 15:171-94. 10.1093\/ecco-jcc\/jjaa161","journal-title":"J Crohns Colitis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000745","article-title":"Review of exclusive enteral therapy in adult Crohn's disease","volume":"8","author":"Mitrev N","year":"2021","unstructured":"Mitrev N, Huang H, Hannah B, Kariyawasam VC. Review of exclusive enteral therapy in adult Crohn's disease. BMJ Open Gastroenterol. 2021, 8:e000745. 10.1136\/bmjgast-2021-000745","journal-title":"BMJ Open Gastroenterol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000542.pub3","article-title":"Enteral nutritional therapy for induction of remission in Crohn's disease","volume":"4","author":"Narula N","year":"2018","unstructured":"Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2018, 4:CD000542. 10.1002\/14651858.CD000542.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112657","article-title":"Enteral nutrition in patients with inflammatory bowel disease. Systematic review, meta-analysis, and meta-regression","volume":"11","author":"Comeche JM","year":"2019","unstructured":"Comeche JM, Caballero P, Gutierrez-Hervas A, Garc\u00eda-Sanjuan S, Comino I, Altavilla C, Tuells J. Enteral nutrition in patients with inflammatory bowel disease. Systematic review, meta-analysis, and meta-regression. Nutrients. 2019, 11:2657. 10.3390\/nu11112657","journal-title":"Nutrients"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goy050","article-title":"Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn's disease","volume":"7","author":"Chen JM","year":"2019","unstructured":"Chen JM, He LW, Yan T, et al.. Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn's disease. Gastroenterol Rep (Oxf). 2019, 7:176-84. 10.1093\/gastro\/goy050","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001162","article-title":"Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn's disease patients: a meta-analysis","volume":"30","author":"Brennan GT","year":"2018","unstructured":"Brennan GT, Ha I, Hogan C, Nguyen E, Jamal MM, Bechtold ML, Nguyen DL. Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn's disease patients: a meta-analysis. Eur J Gastroenterol Hepatol. 2018, 30:997-1002. 10.1097\/MEG.0000000000001162","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.11.026","article-title":"Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and meta-analysis","volume":"21","author":"Limketkai BN","year":"2023","unstructured":"Limketkai BN, Godoy-Brewer G, Parian AM, et al.. Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023, 21:2508-2525.e10. 10.1016\/j.cgh.2022.11.026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.00094","article-title":"Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn's disease: the Indian experience","volume":"18","author":"Sood A","year":"2020","unstructured":"Sood A, Singh A, Sudhakar R, et al.. Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn's disease: the Indian experience. Intest Res. 2020, 18:184-91. 10.5217\/ir.2019.00094","journal-title":"Intest Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.09172","article-title":"Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease","volume":"19","author":"Sharma S","year":"2021","unstructured":"Sharma S, Gupta A, Kedia S, et al.. Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn's disease. Intest Res. 2021, 19:291-300. 10.5217\/ir.2019.09172","journal-title":"Intest Res"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16249","article-title":"Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis","volume":"53","author":"Sahu P","year":"2021","unstructured":"Sahu P, Kedia S, Vuyyuru SK, et al.. Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis. Aliment Pharmacol Ther. 2021, 53:568-76. 10.1111\/apt.16249","journal-title":"Aliment Pharmacol Ther"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad232","article-title":"Exclusive enteral nutrition mediates beneficial gut microbiome enrichment in acute severe colitis","volume":"30","author":"Bajaj A","year":"2024","unstructured":"Bajaj A, Markandey M, Singh M, et al.. Exclusive enteral nutrition mediates beneficial gut microbiome enrichment in acute severe colitis. Inflamm Bowel Dis. 2024, 30:641-50. 10.1093\/ibd\/izad232","journal-title":"Inflamm Bowel Dis"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001859","article-title":"Paediatric inflammatory bowel disease in India: a prospective multicentre study","volume":"32","author":"Srivastava A","year":"2020","unstructured":"Srivastava A, Sathiyasekharan M, Jagadisan B, et al.. Paediatric inflammatory bowel disease in India: a prospective multicentre study. Eur J Gastroenterol Hepatol. 2020, 32:1305-11. 10.1097\/MEG.0000000000001859","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad212.1291","article-title":"P1161 Prevalence of undernutrition in patients with inflammatory bowel disease and improvement after nutritional advice","volume":"18","author":"Kutar M","year":"2024","unstructured":"Kutar M, Dharap V, Dhoble P, Trinidade S, Gupta T, Abraham P, Desai D. P1161 Prevalence of undernutrition in patients with inflammatory bowel disease and improvement after nutritional advice. J Crohns Colitis. 2024, 18:i2058. 10.1093\/ecco-jcc\/jjad212.1291","journal-title":"J Crohns Colitis"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review","volume":"166","author":"Hashash JG","year":"2024","unstructured":"Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology. 2024, 166:521-32. 10.1053\/j.gastro.2023.11.303","journal-title":"Gastroenterology"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka K","year":"2018","unstructured":"Matsuoka K, Kobayashi T, Ueno F, et al.. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018, 53:305-53. 10.1007\/s00535-018-1439-1","journal-title":"J Gastroenterol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i43.7652","article-title":"Use of exclusive enteral nutrition in adults with Crohn's disease: a review","volume":"19","author":"Wall CL","year":"2013","unstructured":"Wall CL, Day AS, Gearry RB. Use of exclusive enteral nutrition in adults with Crohn's disease: a review. World J Gastroenterol. 2013, 19:7652-60. 10.3748\/wjg.v19.i43.7652","journal-title":"World J Gastroenterol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12829","article-title":"Exclusive enteral nutrition in the management of Crohn's disease: a qualitative exploration of experiences, challenges and enablers in adult patients","volume":"34","author":"Mutsekwa RN","year":"2021","unstructured":"Mutsekwa RN, Edwards JT, Angus RL. Exclusive enteral nutrition in the management of Crohn's disease: a qualitative exploration of experiences, challenges and enablers in adult patients. J Hum Nutr Diet. 2021, 34:440-9. 10.1111\/jhn.12829","journal-title":"J Hum Nutr Diet"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-023-01431-y","article-title":"Dietary interventions in Crohn's disease: a simple solution to refractory disease","volume":"43","author":"Vadlapudi SS","year":"2024","unstructured":"Vadlapudi SS, Poddar U. Dietary interventions in Crohn's disease: a simple solution to refractory disease. Indian J Gastroenterol. 2024, 43:18-21. 10.1007\/s12664-023-01431-y","journal-title":"Indian J Gastroenterol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112627","article-title":"Compliance and adherence to enteral nutrition treatment in adults: a systematic review","volume":"11","author":"Gea Cabrera A","year":"2019","unstructured":"Gea Cabrera A, Sanz-Lorente M, Sanz-Valero J, L\u00f3pez-Pintor E. Compliance and adherence to enteral nutrition treatment in adults: a systematic review. Nutrients. 2019, 11:2627. 10.3390\/nu11112627","journal-title":"Nutrients"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1177\/0148607116673053","article-title":"ASPEN safe practices for enteral nutrition therapy","volume":"41","author":"Boullata JI","year":"2017","unstructured":"Boullata JI, Carrera AL, Harvey L, et al.. ASPEN safe practices for enteral nutrition therapy. JPEN J Parenter Enteral Nutr. 2017, 41:15-103. 10.1177\/0148607116673053","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12002","article-title":"Impact of dietary beliefs and practices on patients with inflammatory bowel disease: an observational study from India","volume":"1","author":"Tomar SK","year":"2017","unstructured":"Tomar SK, Kedia S, Upadhyay AD, et al.. Impact of dietary beliefs and practices on patients with inflammatory bowel disease: an observational study from India. JGH Open. 2017, 1:15-21. 10.1002\/jgh3.12002","journal-title":"JGH Open"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-024-01539-9","article-title":"Comprehensive assessment of nutritional and functional status of patients with ulcerative colitis and their impact on quality of life","volume":"43","author":"Sachan A","year":"2024","unstructured":"Sachan A, Thungapathra M, Kaur H, et al.. Comprehensive assessment of nutritional and functional status of patients with ulcerative colitis and their impact on quality of life. Indian J Gastroenterol. 2024, 43:254-63. 10.1007\/s12664-024-01539-9","journal-title":"Indian J Gastroenterol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12256","article-title":"Exclusive enteral nutrition: an optimal care pathway for use in adult patients with active Crohn's disease","volume":"4","author":"Day A","year":"2020","unstructured":"Day A, Wood J, Melton S, Bryant RV. Exclusive enteral nutrition: an optimal care pathway for use in adult patients with active Crohn's disease. JGH Open. 2020, 4:260-6. 10.1002\/jgh3.12256","journal-title":"JGH Open"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_936_18","article-title":"Inflammatory bowel disease: an Indian perspective","volume":"153","author":"Jain M","year":"2021","unstructured":"Jain M, Venkataraman J. Inflammatory bowel disease: an Indian perspective. Indian J Med Res. 2021, 153:421-30. 10.4103\/ijmr.IJMR_936_18","journal-title":"Indian J Med Res"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040896","article-title":"What should I eat? Dietary recommendations for patients with inflammatory bowel disease","volume":"15","author":"Saha S","year":"2023","unstructured":"Saha S, Patel N. What should I eat? Dietary recommendations for patients with inflammatory bowel disease. Nutrients. 2023, 15:896. 10.3390\/nu15040896","journal-title":"Nutrients"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine A","year":"2019","unstructured":"Levine A, Wine E, Assa A, et al.. Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019, 157:440-450.e8. 10.1053\/j.gastro.2019.04.021","journal-title":"Gastroenterology"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.55489\/njcm.161020255875","article-title":"Effect of low\/very low-calorie and other special diets on anthropometric and cardio-metabolic parameters of diabetes mellitus patients: a systematic review and meta-analysis","volume":"16","author":"Gupta B","year":"2025","unstructured":"Gupta B, Singh R, Verma N, Gupta K, Datta G, Mittal A. Effect of low\/very low-calorie and other special diets on anthropometric and cardio-metabolic parameters of diabetes mellitus patients: a systematic review and meta-analysis. Natl J Community Med. 2025, 16:1021-36. 10.55489\/njcm.161020255875","journal-title":"Natl J Community Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.71480\/nmj.v66i1.601","article-title":"Association of gut-microbiome and mental health and effects of probiotics on psychiatric disorders: a meta-analysis and systematic review","volume":"66","author":"Goel R","year":"2025","unstructured":"Goel R, Gupta B, Satodiya VN, Vala AU, Dabhi H, Mittal A. Association of gut-microbiome and mental health and effects of probiotics on psychiatric disorders: a meta-analysis and systematic review. Niger Med J. 2025, 66:13-25. 10.71480\/nmj.v66i1.601","journal-title":"Niger Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/527365-alternative-medicine-and-nutritional-therapy-in-adult-inflammatory-bowel-disease-in-india-a-move-towards-holistic-practice","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:37:00Z","timestamp":1789256220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/527365-alternative-medicine-and-nutritional-therapy-in-adult-inflammatory-bowel-disease-in-india-a-move-towards-holistic-practice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":79,"URL":"https:\/\/doi.org\/10.7759\/cureus.116152","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}